New or improved vaccines anticipated by 2015:
Rotavirus °
Human papilloma virus °
Pneumococcus (improved conjugate or protein-based) °
Japanese B encephalitis (improved) °
Meningococcus A (multi-serotype conjugate)°
Measles (aerosol)°
Polio (inactivated vaccines based on Sabin strains)°
Polio (monovalent OPV type 1)°°
Dengue°°
Group A Streptococcus°°
RSV°°
Shigella°°
ETEC°°
Typhoid (conjugate)°°
West Nile Fever°°
SARS°°
Malaria°°
DTaP (with two P antigens)°°
New combinations of existing vaccines°°
Influenza for pandemic response
° Late stage of development
°°Licensing expected in 2010-2015